发明授权
- 专利标题： Hybrid polypeptides with selectable properties
- 专利标题（中）： 具有可选性质的杂交多肽
-
申请号： US13323608申请日： 2011-12-12
-
公开(公告)号： US08697647B2公开(公告)日： 2014-04-15
- 发明人: Odile Esther Levy , Michael R. Hanley , Carolyn M. Jodka , Diana Y. Lewis , Christopher J. Soares , Soumitra S. Ghosh , Lawrence J. D'Souza , David G. Parkes , Christine M. Mack
- 申请人： Odile Esther Levy , Michael R. Hanley , Carolyn M. Jodka , Diana Y. Lewis , Christopher J. Soares , Soumitra S. Ghosh , Lawrence J. D'Souza , David G. Parkes , Christine M. Mack
- 代理机构： Kilpatrick Townsend & Stockton LLP
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K38/26
摘要：
The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
公开/授权文献
- US20120253023A1 HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES 公开/授权日：2012-10-04